Loading…

Matrix metalloproteinases in peripheral vascular disease

Matrix metalloproteinases (MMPs) are extracellular matrix–modifying enzymes that are important in many physiologic and pathologic vascular processes. Dysregulation of MMP activity has been associated with common vascular diseases such as atherosclerotic plaque formation, abdominal aortic aneurysms,...

Full description

Saved in:
Bibliographic Details
Published in:Journal of vascular surgery 2007-04, Vol.45 (4), p.849-857
Main Authors: Hobeika, Mark J., MD, Thompson, Robert W., MD, Muhs, Bart E., MD, Brooks, Peter C., PhD, Gagne, Paul J., MD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c449t-8a4db12babe4f59afbab140fdcce21600cde15a82a21c7a7e72e84e9d2e29b2a3
cites cdi_FETCH-LOGICAL-c449t-8a4db12babe4f59afbab140fdcce21600cde15a82a21c7a7e72e84e9d2e29b2a3
container_end_page 857
container_issue 4
container_start_page 849
container_title Journal of vascular surgery
container_volume 45
creator Hobeika, Mark J., MD
Thompson, Robert W., MD
Muhs, Bart E., MD
Brooks, Peter C., PhD
Gagne, Paul J., MD
description Matrix metalloproteinases (MMPs) are extracellular matrix–modifying enzymes that are important in many physiologic and pathologic vascular processes. Dysregulation of MMP activity has been associated with common vascular diseases such as atherosclerotic plaque formation, abdominal aortic aneurysms, and critical limb ischemia. For this reason, MMPs have become an important focus for basic science studies and clinical investigations by vascular biology researchers. This article reviews the recent literature, summarizing our current understanding of the role of MMPs in the pathogenesis of various peripheral vascular disease states. In addition, the importance of MMPs in the future diagnosis and treatment of peripheral vascular disease is discussed.
doi_str_mv 10.1016/j.jvs.2006.09.066
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70338410</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0741521406022531</els_id><sourcerecordid>70338410</sourcerecordid><originalsourceid>FETCH-LOGICAL-c449t-8a4db12babe4f59afbab140fdcce21600cde15a82a21c7a7e72e84e9d2e29b2a3</originalsourceid><addsrcrecordid>eNp9kU9r3DAQxUVJSTZpP0Avxafc7M7I8h9RKJTQNoWUHpqcxVgeU7laeyvZS_Pto2UXCjnkNAPz3mPmN0K8QygQsP4wFuM-FhKgLkAXUNevxAZBN3ndgj4TG2gU5pVEdSEuYxwBEKu2ORcX2JS6VYAb0f6gJbh_2ZYX8n7ehXlhN1HkmLkp23Fwu98cyGd7inb1FLLeRU7zN-L1QD7y21O9Eg9fv9zf3OZ3P799v_l8l1ul9JK3pPoOZUcdq6HSNKQOFQy9tSyxBrA9Y0WtJIm2oYYbya1i3UuWupNUXonrY25a7e_KcTFbFy17TxPPazQNlGWrEJIQj0Ib5hgDD2YX3JbCo0EwB1xmNAmXOeAyoE3ClTzvT-Frt-X-v-PEJwk-HgWcTtw7DiZax5Pl3gW2i-ln92L8p2du693kLPk__MhxnNcwJXYGTZQGzK_Dvw7vghqkrEosnwDWVZEz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70338410</pqid></control><display><type>article</type><title>Matrix metalloproteinases in peripheral vascular disease</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><creator>Hobeika, Mark J., MD ; Thompson, Robert W., MD ; Muhs, Bart E., MD ; Brooks, Peter C., PhD ; Gagne, Paul J., MD</creator><creatorcontrib>Hobeika, Mark J., MD ; Thompson, Robert W., MD ; Muhs, Bart E., MD ; Brooks, Peter C., PhD ; Gagne, Paul J., MD</creatorcontrib><description>Matrix metalloproteinases (MMPs) are extracellular matrix–modifying enzymes that are important in many physiologic and pathologic vascular processes. Dysregulation of MMP activity has been associated with common vascular diseases such as atherosclerotic plaque formation, abdominal aortic aneurysms, and critical limb ischemia. For this reason, MMPs have become an important focus for basic science studies and clinical investigations by vascular biology researchers. This article reviews the recent literature, summarizing our current understanding of the role of MMPs in the pathogenesis of various peripheral vascular disease states. In addition, the importance of MMPs in the future diagnosis and treatment of peripheral vascular disease is discussed.</description><identifier>ISSN: 0741-5214</identifier><identifier>EISSN: 1097-6809</identifier><identifier>DOI: 10.1016/j.jvs.2006.09.066</identifier><identifier>PMID: 17398401</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Animals ; Aortic Aneurysm, Abdominal - drug therapy ; Aortic Aneurysm, Abdominal - enzymology ; Atherosclerosis - drug therapy ; Atherosclerosis - enzymology ; Biomarkers - metabolism ; Constriction, Pathologic - drug therapy ; Constriction, Pathologic - enzymology ; Constriction, Pathologic - surgery ; Enzyme Inhibitors - pharmacology ; Enzyme Inhibitors - therapeutic use ; Extremities - blood supply ; Humans ; Ischemia - drug therapy ; Ischemia - enzymology ; Matrix Metalloproteinases, Secreted - antagonists &amp; inhibitors ; Matrix Metalloproteinases, Secreted - metabolism ; Peripheral Vascular Diseases - diagnosis ; Peripheral Vascular Diseases - drug therapy ; Peripheral Vascular Diseases - enzymology ; Recurrence ; Surgery ; Tissue Inhibitor of Metalloproteinases - metabolism ; Varicose Ulcer - drug therapy ; Varicose Ulcer - enzymology ; Varicose Veins - drug therapy ; Varicose Veins - enzymology ; Vascular Surgical Procedures - adverse effects ; Venous Thrombosis - drug therapy ; Venous Thrombosis - enzymology</subject><ispartof>Journal of vascular surgery, 2007-04, Vol.45 (4), p.849-857</ispartof><rights>The Society for Vascular Surgery</rights><rights>2007 The Society for Vascular Surgery</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c449t-8a4db12babe4f59afbab140fdcce21600cde15a82a21c7a7e72e84e9d2e29b2a3</citedby><cites>FETCH-LOGICAL-c449t-8a4db12babe4f59afbab140fdcce21600cde15a82a21c7a7e72e84e9d2e29b2a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17398401$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hobeika, Mark J., MD</creatorcontrib><creatorcontrib>Thompson, Robert W., MD</creatorcontrib><creatorcontrib>Muhs, Bart E., MD</creatorcontrib><creatorcontrib>Brooks, Peter C., PhD</creatorcontrib><creatorcontrib>Gagne, Paul J., MD</creatorcontrib><title>Matrix metalloproteinases in peripheral vascular disease</title><title>Journal of vascular surgery</title><addtitle>J Vasc Surg</addtitle><description>Matrix metalloproteinases (MMPs) are extracellular matrix–modifying enzymes that are important in many physiologic and pathologic vascular processes. Dysregulation of MMP activity has been associated with common vascular diseases such as atherosclerotic plaque formation, abdominal aortic aneurysms, and critical limb ischemia. For this reason, MMPs have become an important focus for basic science studies and clinical investigations by vascular biology researchers. This article reviews the recent literature, summarizing our current understanding of the role of MMPs in the pathogenesis of various peripheral vascular disease states. In addition, the importance of MMPs in the future diagnosis and treatment of peripheral vascular disease is discussed.</description><subject>Animals</subject><subject>Aortic Aneurysm, Abdominal - drug therapy</subject><subject>Aortic Aneurysm, Abdominal - enzymology</subject><subject>Atherosclerosis - drug therapy</subject><subject>Atherosclerosis - enzymology</subject><subject>Biomarkers - metabolism</subject><subject>Constriction, Pathologic - drug therapy</subject><subject>Constriction, Pathologic - enzymology</subject><subject>Constriction, Pathologic - surgery</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Enzyme Inhibitors - therapeutic use</subject><subject>Extremities - blood supply</subject><subject>Humans</subject><subject>Ischemia - drug therapy</subject><subject>Ischemia - enzymology</subject><subject>Matrix Metalloproteinases, Secreted - antagonists &amp; inhibitors</subject><subject>Matrix Metalloproteinases, Secreted - metabolism</subject><subject>Peripheral Vascular Diseases - diagnosis</subject><subject>Peripheral Vascular Diseases - drug therapy</subject><subject>Peripheral Vascular Diseases - enzymology</subject><subject>Recurrence</subject><subject>Surgery</subject><subject>Tissue Inhibitor of Metalloproteinases - metabolism</subject><subject>Varicose Ulcer - drug therapy</subject><subject>Varicose Ulcer - enzymology</subject><subject>Varicose Veins - drug therapy</subject><subject>Varicose Veins - enzymology</subject><subject>Vascular Surgical Procedures - adverse effects</subject><subject>Venous Thrombosis - drug therapy</subject><subject>Venous Thrombosis - enzymology</subject><issn>0741-5214</issn><issn>1097-6809</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNp9kU9r3DAQxUVJSTZpP0Avxafc7M7I8h9RKJTQNoWUHpqcxVgeU7laeyvZS_Pto2UXCjnkNAPz3mPmN0K8QygQsP4wFuM-FhKgLkAXUNevxAZBN3ndgj4TG2gU5pVEdSEuYxwBEKu2ORcX2JS6VYAb0f6gJbh_2ZYX8n7ehXlhN1HkmLkp23Fwu98cyGd7inb1FLLeRU7zN-L1QD7y21O9Eg9fv9zf3OZ3P799v_l8l1ul9JK3pPoOZUcdq6HSNKQOFQy9tSyxBrA9Y0WtJIm2oYYbya1i3UuWupNUXonrY25a7e_KcTFbFy17TxPPazQNlGWrEJIQj0Ib5hgDD2YX3JbCo0EwB1xmNAmXOeAyoE3ClTzvT-Frt-X-v-PEJwk-HgWcTtw7DiZax5Pl3gW2i-ln92L8p2du693kLPk__MhxnNcwJXYGTZQGzK_Dvw7vghqkrEosnwDWVZEz</recordid><startdate>20070401</startdate><enddate>20070401</enddate><creator>Hobeika, Mark J., MD</creator><creator>Thompson, Robert W., MD</creator><creator>Muhs, Bart E., MD</creator><creator>Brooks, Peter C., PhD</creator><creator>Gagne, Paul J., MD</creator><general>Mosby, Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070401</creationdate><title>Matrix metalloproteinases in peripheral vascular disease</title><author>Hobeika, Mark J., MD ; Thompson, Robert W., MD ; Muhs, Bart E., MD ; Brooks, Peter C., PhD ; Gagne, Paul J., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c449t-8a4db12babe4f59afbab140fdcce21600cde15a82a21c7a7e72e84e9d2e29b2a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Animals</topic><topic>Aortic Aneurysm, Abdominal - drug therapy</topic><topic>Aortic Aneurysm, Abdominal - enzymology</topic><topic>Atherosclerosis - drug therapy</topic><topic>Atherosclerosis - enzymology</topic><topic>Biomarkers - metabolism</topic><topic>Constriction, Pathologic - drug therapy</topic><topic>Constriction, Pathologic - enzymology</topic><topic>Constriction, Pathologic - surgery</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Enzyme Inhibitors - therapeutic use</topic><topic>Extremities - blood supply</topic><topic>Humans</topic><topic>Ischemia - drug therapy</topic><topic>Ischemia - enzymology</topic><topic>Matrix Metalloproteinases, Secreted - antagonists &amp; inhibitors</topic><topic>Matrix Metalloproteinases, Secreted - metabolism</topic><topic>Peripheral Vascular Diseases - diagnosis</topic><topic>Peripheral Vascular Diseases - drug therapy</topic><topic>Peripheral Vascular Diseases - enzymology</topic><topic>Recurrence</topic><topic>Surgery</topic><topic>Tissue Inhibitor of Metalloproteinases - metabolism</topic><topic>Varicose Ulcer - drug therapy</topic><topic>Varicose Ulcer - enzymology</topic><topic>Varicose Veins - drug therapy</topic><topic>Varicose Veins - enzymology</topic><topic>Vascular Surgical Procedures - adverse effects</topic><topic>Venous Thrombosis - drug therapy</topic><topic>Venous Thrombosis - enzymology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hobeika, Mark J., MD</creatorcontrib><creatorcontrib>Thompson, Robert W., MD</creatorcontrib><creatorcontrib>Muhs, Bart E., MD</creatorcontrib><creatorcontrib>Brooks, Peter C., PhD</creatorcontrib><creatorcontrib>Gagne, Paul J., MD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of vascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hobeika, Mark J., MD</au><au>Thompson, Robert W., MD</au><au>Muhs, Bart E., MD</au><au>Brooks, Peter C., PhD</au><au>Gagne, Paul J., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Matrix metalloproteinases in peripheral vascular disease</atitle><jtitle>Journal of vascular surgery</jtitle><addtitle>J Vasc Surg</addtitle><date>2007-04-01</date><risdate>2007</risdate><volume>45</volume><issue>4</issue><spage>849</spage><epage>857</epage><pages>849-857</pages><issn>0741-5214</issn><eissn>1097-6809</eissn><abstract>Matrix metalloproteinases (MMPs) are extracellular matrix–modifying enzymes that are important in many physiologic and pathologic vascular processes. Dysregulation of MMP activity has been associated with common vascular diseases such as atherosclerotic plaque formation, abdominal aortic aneurysms, and critical limb ischemia. For this reason, MMPs have become an important focus for basic science studies and clinical investigations by vascular biology researchers. This article reviews the recent literature, summarizing our current understanding of the role of MMPs in the pathogenesis of various peripheral vascular disease states. In addition, the importance of MMPs in the future diagnosis and treatment of peripheral vascular disease is discussed.</abstract><cop>United States</cop><pub>Mosby, Inc</pub><pmid>17398401</pmid><doi>10.1016/j.jvs.2006.09.066</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0741-5214
ispartof Journal of vascular surgery, 2007-04, Vol.45 (4), p.849-857
issn 0741-5214
1097-6809
language eng
recordid cdi_proquest_miscellaneous_70338410
source BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS
subjects Animals
Aortic Aneurysm, Abdominal - drug therapy
Aortic Aneurysm, Abdominal - enzymology
Atherosclerosis - drug therapy
Atherosclerosis - enzymology
Biomarkers - metabolism
Constriction, Pathologic - drug therapy
Constriction, Pathologic - enzymology
Constriction, Pathologic - surgery
Enzyme Inhibitors - pharmacology
Enzyme Inhibitors - therapeutic use
Extremities - blood supply
Humans
Ischemia - drug therapy
Ischemia - enzymology
Matrix Metalloproteinases, Secreted - antagonists & inhibitors
Matrix Metalloproteinases, Secreted - metabolism
Peripheral Vascular Diseases - diagnosis
Peripheral Vascular Diseases - drug therapy
Peripheral Vascular Diseases - enzymology
Recurrence
Surgery
Tissue Inhibitor of Metalloproteinases - metabolism
Varicose Ulcer - drug therapy
Varicose Ulcer - enzymology
Varicose Veins - drug therapy
Varicose Veins - enzymology
Vascular Surgical Procedures - adverse effects
Venous Thrombosis - drug therapy
Venous Thrombosis - enzymology
title Matrix metalloproteinases in peripheral vascular disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T09%3A51%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Matrix%20metalloproteinases%20in%20peripheral%20vascular%20disease&rft.jtitle=Journal%20of%20vascular%20surgery&rft.au=Hobeika,%20Mark%20J.,%20MD&rft.date=2007-04-01&rft.volume=45&rft.issue=4&rft.spage=849&rft.epage=857&rft.pages=849-857&rft.issn=0741-5214&rft.eissn=1097-6809&rft_id=info:doi/10.1016/j.jvs.2006.09.066&rft_dat=%3Cproquest_cross%3E70338410%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c449t-8a4db12babe4f59afbab140fdcce21600cde15a82a21c7a7e72e84e9d2e29b2a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70338410&rft_id=info:pmid/17398401&rfr_iscdi=true